Katharine Ruhl
Psychiatry · Skokie, ILNPI 1881885572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 24.3% of the total. 2025 is the largest year on record at $1,430, 5.6 times the $254 reported in 2019.
Across 151 payments — averaging $23.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$860
- AbbVie$758
- Lundbeck LLC$446
- Otsuka America Pharmaceutical, Inc.$365
- Johnson & Johnson$321
- Takeda Pharmaceuticals U.S.A., Inc.$169
- plus $620 from 15 others
What the payments were for
- Food & beverage$3,539100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $860 |
| AbbVie(2 entities) | 31 | $758 |
| Lundbeck LLC | 22 | $446 |
| Otsuka America Pharmaceutical, Inc. | 17 | $365 |
| Johnson & Johnson | 15 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $169 |
| Vanda Pharmaceuticals Inc. | 4 | $105 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| Bausch Health US, LLC | 3 | $46 |
| TMS Neurohealth Centers Inc. | 1 | $43 |
| OWP Pharmaceuticals, Inc. | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Corium, LLC | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
How this compares
$3,539 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 12 | $5,072 |
| Buspirone Hcl | 122 | $3,317 |
| Quetiapine Fumarate | 80 | $3,039 |
| Sertraline Hcl | 118 | $1,456 |
| Lamotrigine | 122 | $1,329 |
| Bupropion XlBupropion Hcl | 43 | $1,058 |
| Fluoxetine Hcl | 77 | $1,045 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $984 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $610 |
| Gabapentin | 33 | $565 |
| Escitalopram Oxalate | 52 | $540 |
| Duloxetine Hcl | 23 | $468 |
| Mirtazapine | 24 | $463 |
| Alprazolam | 38 | $456 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 25 | $398 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Skokie
- Mark ShukhmanSkokie$250K
- John ZajeckaSkokie$76K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Abid NazeerOak Brook$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.